BM-573, a thromboxane receptor antagonist, reduces development of atherosclerosis in apo E-deficient mice

Céline Cherdon, Stéphanie Rolin, Julien Hanson, PV Drion, Laurence De Leval, Jean-Olivier Defraigne, Jean-Michel Dogné

Research output: Contribution to journalArticlepeer-review

Original languageUndefined/Unknown
Pages (from-to)S33-S34
JournalJournal of Molecular and Cellular Cardiology
Issue number6
Publication statusPublished - 2007

Cite this